Despite a challenging landscape for many European unicorns, Alan, a pioneering health insurance startup from France, has successfully elevated its valuation to €5 billion (approximately $5.83 billion), a notable increase from its previous valuation of $4.5 billion in 2024.
Founded in 2016, Alan has rapidly expanded, now employing a team of 740 and providing health insurance and wellness services to over one million individuals, including employees, freelancers, and retirees. The company's innovative app allows users to manage reimbursements, consult with doctors, and monitor their health habits seamlessly. CEO Jean-Charles Samuelian-Werve expressed ambitions to invest significantly in technology and artificial intelligence, reflecting the company's forward-thinking approach.
The latest valuation was bolstered by a €100 million funding round ($116 million), primarily led by existing investor Index Ventures, alongside contributions from new investors such as Greenoaks, Kaaf, and SH. Notable business figures, including Shopify founder Tobi Lütke and 2018 FIFA World Cup champion Antoine Griezmann, also participated as angel investors. Additionally, Belfius, a strategic partner, was involved in this funding round.
Alan has recently secured a contract to provide health insurance for up to 135,000 civil servants and their families, complementing its existing private-sector agreements in France and internationally. The company reported an impressive €785 million (around $915 million) in annual recurring revenue for 2025, marking a 53% increase from the previous year.
While specific financial figures remain undisclosed, Alan has announced that it has achieved operational profitability within France, where it became the first independent insurance provider to obtain a license since the 1980s. The company has extended its reach into Belgium and Spain, serving clients such as HP and Volkswagen, and has recently begun operations in Canada, where it is now licensed across all provinces.
Alan is focused on international growth and enhancing its product offerings, aiming for $1.16 billion in annual recurring revenue by 2026, prioritizing expansion over immediate profitability. This strategic vision appears to resonate well with investors, who are optimistic about the company's potential for future success.
